This invention provides the application of wrinkled papaya polyphenols in the preparation of drugs for treating
osteoarthritis. The wrinkled papaya polyphenols are used in the preparation of drugs that reduce the release of pro-inflammatory cytokines and the
inflammatory mediator NO in primary chondrocytes, and / or reduce the
mRNA expression of
inflammation-related enzymes, and / or inhibit the
phosphorylation of proteins related to the NF-κB signaling pathway. To test and clarify the anti-inflammatory effect of wrinkled papaya polyphenols, an ADTC5 primary
chondrocyte inflammation model was constructed for observation. The results showed that wrinkled papaya polyphenols significantly inhibited IL-1β-induced
inflammation in ADTC5 primary chondrocytes, effectively reduced the
secretion of pro-inflammatory cytokines (IL-6 and TNF-α), inhibited the release of the
inflammatory mediator NO, downregulated the
mRNA expression of inflammatory enzymes (iNOS and Cox-2), and reduced the
phosphorylation of IκBα and p65 proteins.